Literature DB >> 1635162

[Clinical evaluation of traditional Chinese medicine for chronic idiopathic thrombocytopenic purpura].

S Nakayama1, A Matsushita, S Ichiba, H Yabe, K Nagai.   

Abstract

The efficacy of traditional Chinese medicine (Kampo medicine) was examined in 40 patients with steroid-unresponsive idiopathic thrombocytopenic purpura (ITP). All patients were, at first, given Hochuekihi-to, and when they were refractory, therapy was switched to Sairei-to, Ninjinyoei-to, and Kamikihi-to. The efficacy rate was 20.0% by Hochuekihi-to, 20.7% by Sairei-to, 5.5% by Ninjinyoei-to and 6.7% by Kamikihi-to, respectively. Thus, overall responders were 12 in 40 patients with an effective rate of 30.0%. The mechanism of action of traditional Chinese medicine is discussed in relation to the production of various kinds of cytokines.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1635162

Source DB:  PubMed          Journal:  Rinsho Ketsueki        ISSN: 0485-1439


  2 in total

1.  AZD4547 targets the FGFR/Akt/SOX2 axis to overcome paclitaxel resistance in head and neck cancer.

Authors:  Abdulmelik Aytatli; Neslisah Barlak; Fatma Sanli; Hasan Onur Caglar; Betul Gundogdu; Arzu Tatar; Michael Ittmann; Omer Faruk Karatas
Journal:  Cell Oncol (Dordr)       Date:  2021-11-27       Impact factor: 6.730

2.  Silencing growth hormone receptor inhibits estrogen receptor negative breast cancer through ATP-binding cassette sub-family G member 2.

Authors:  Arunkumar Arumugam; Ramadevi Subramani; Sushmita Bose Nandy; Daniel Terreros; Alok Kumar Dwivedi; Edward Saltzstein; Rajkumar Lakshmanaswamy
Journal:  Exp Mol Med       Date:  2019-01-07       Impact factor: 8.718

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.